Skip to main content
. 2022 Jul 21;95(1137):20210896. doi: 10.1259/bjr.20210896

Table 2.

Therapeutic response of salvage PRRT

Response Clinical symptomatic response evaluation (No. of patients) Biochemical response evaluation (No. of patients) PERCIST (No. of patients) 68Ga-DOTATATE RECIST 1.1 (No. of patients)
Complete response 1 (4.5%) 1 (4.5%) 0 0
Partial response 1 (4.5%) 1 (4.5%) 2 (9%) 1 (4.5%)
Stable disease 13 (59.1%) 15 (68.3%) 12 (54.6%) 13 (59.1%)
Progressive disease 7 (31.9%) 5 (22.7%) 8 (36.4%) 8 (36.4%)

PRRT, peptide receptor radionuclide therapy.